Breaking News

Autolomous to Expedite Digitization of Batch Verification

Will work to develop AutoloMATE-Assist, a digital batch verification technology for cell and gene therapies to alleviate paper based bottlenecks.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Autolomous LTD, a developer of critical manufacturing management systems for cell and gene therapies, received a loan from UK Research and Innovation (UKRI), the public innovation agency, to help address manufacturing challenges.    Autolomous will work to expedite development of AutoloMATE-Assist, its digital batch verification technology for cell and gene therapies (CGT). The project began in April 2021 and is expected to last 24 months.    AutoloMATE-Assist is the third module from Autolo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters